Neurofilament Heavy polypeptideCpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response

Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma

(2013) K Gebauer et al.   BRITISH JOURNAL OF CANCER

Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation

(2013) Payal Kapur et al.   LANCET ONCOLOGY

A prognostic model for metastatic renal-cell carcinoma

(2013) Matthew D Galsky   LANCET ONCOLOGY

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

(2013) Daniel YC Heng et al.   LANCET ONCOLOGY

Comprehensive molecular characterization of clear cell renal cell carcinoma

(2013)   NATURE

GATA5CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progression

(2012) Inga Peters et al.   BJU INTERNATIONAL

SFRP1CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence

(2012) Faranaz Atschekzei et al.   Epigenetics

Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma

(2012) Christoph Seidel et al.   EUROPEAN JOURNAL OF CANCER

Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer

(2012) Sakari Vanharanta et al.   NATURE MEDICINE

Epigenetic regulation in RCC: opportunities for therapeutic intervention?

(2012) James Larkin et al.   Nature Reviews Urology

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

(2011) Ignacio Varela et al.   NATURE

Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

(2010) Cora N. Sternberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes

(2010) Gillian L. Dalgliesh et al.   NATURE

Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma

(2010) M R Morris et al.   ONCOGENE

Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma

(2010) M A T Hildebrandt et al.   ONCOGENE

Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma

(2010) M R Morris et al.   ONCOGENE

Neurofilament Heavy Polypeptide Regulates the Akt-β-Catenin Pathway in Human Esophageal Squamous Cell Carcinoma

(2010) Myoung Sook Kim et al.   PLoS One

Prognostic Significance of Gremlin1 (GREM1) Promoter CpG Island Hypermethylation in Clear Cell Renal Cell Carcinoma

(2009) Iris J.H. van Vlodrop et al.   AMERICAN JOURNAL OF PATHOLOGY

The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history

(2009) Daiji Oka et al.   CANCER

Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma

(2008) M R Morris et al.   BRITISH JOURNAL OF CANCER

Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors

(2008) M. L. Nickerson et al.   CLINICAL CANCER RESEARCH

Review of the Multiple Aspects of Neurofilament Functions, and their Possible Contribution to Neurodegeneration

(2008) Rodolphe Perrot et al.   MOLECULAR NEUROBIOLOGY